IceCure Medical (ICCM) Equity Ratio (2020 - 2025)

IceCure Medical (ICCM) has 6 years of Equity Ratio data on file, last reported at 0.65 in Q4 2025.

• Equity Ratio for Q4 2025 came in at 0.65, up 18.76% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.65 (up 18.76% YoY), and the FY2025 annual result was 0.65, up 18.76% from the prior year.
• Equity Ratio rose to 0.65 in Q4 2025 per ICCM's latest filing, from 0.55 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.84 in Q4 2022 and troughed at 0.55 in Q4 2024.
• A 5-year average of 0.72 and a median of 0.74 in 2023 frame the typical range for Equity Ratio.
• The sharpest annual moves came in 2021 and 2024: Equity Ratio surged 51.39% in 2021, then dropped 25.96% in 2024.
• A 5-year view of Equity Ratio shows it stood at 0.84 in 2021, then grew by 0.84% to 0.84 in 2022, then retreated by 11.98% to 0.74 in 2023, then declined by 25.96% to 0.55 in 2024, then rose by 18.76% to 0.65 in 2025.
• Business Quant data shows ICCM's Equity Ratio at 0.65 in Q4 2025, 0.55 in Q4 2024, and 0.74 in Q4 2023.